Cited by

• A new model for multiple sclerosis: chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane.

  Tsukada N, Koh CS, Yanagisawa N, Okano A, Behan WM, Behan PO. Tsukada N, et al. Acta Neuropathol. 1987;73(3):259-66. doi: 10.1007/BF00686620. Acta Neuropathol. 1987. PMID: 3618117
• Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.

  Warrington AE, Rodriguez M. Warrington AE, et al. Curr Top Microbiol Immunol. 2008;318:213-39. doi: 10.1007/978-3-540-73677-6_9. Curr Top Microbiol Immunol. 2008. PMID: 18219820 Free PMC article. Review.
• Experimental allergic encephalomyelitis. Frequent sampling of blood alters disease course.

  Traugott U, Raine CS. Traugott U, et al. Acta Neuropathol. 1979 Dec;48(3):171-5. doi: 10.1007/BF00690517. Acta Neuropathol. 1979. PMID: 525258
• Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

  Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Smith ME, et al. Am J Pathol. 1999 Oct;155(4):1147-61. doi: 10.1016/S0002-9440(10)65218-2. Am J Pathol. 1999. PMID: 10514398 Free PMC article.
• Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.

  Traugott U. Traugott U. Springer Semin Immunopathol. 1985;8(1-2):71-95. doi: 10.1007/BF00197248. Springer Semin Immunopathol. 1985. PMID: 3890238 Review. No abstract available.